Literature DB >> 6341008

Carcinoembryonic antigen detection by immunocytochemical methods in carcinomas of the colon and stomach.

L Nakopoulou, M Zinozi, G Theodoropoulos, N Papacharalampous.   

Abstract

CEA was studied in paraffin sections from 50 cases of colonic and 50 cases of gastric adenocarcinoma using immunoperoxidase and immunofluorescence techniques. CEA was positive more frequently in colonic (86 per cent) than in stomach carcinoma (76 per cent). Immunoperoxidase was found to be the more sensitive technique for the detection of CEA in both organs. The non-neoplastic peritumoral colonic mucosa was more often CEA positive than was the peritumoral gastric mucosa. CEA was found more often, and the intensity of the staining was stronger in well-differentiated colonic and gastric carcinoma than it was in poorly differentiated carcinoma. No relation was found between the presence of CEA in colonic and gastric carcinoma and the stages of the disease. CEA was detected more frequently in carcinomas of the left colon than in carcinomas of the right colon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341008     DOI: 10.1007/bf02562496

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Morphological predictors of survival in advanced gastric carcinoma univariate and multivariate analysis.

Authors:  P Schmitz-Moormann; C Pohl; G W Himmelmann; K Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.

Authors:  Hye Won Chung; Hoon Young Kong; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

3.  Comparative study of CEA staining in gastric and colorectal cancer tissues.

Authors:  O Kojima; T Tanioku; N Kitagawa; Y Uehara; T Majima; E Ikeda; N Iwai; Y Fujita; S Majima
Journal:  Gastroenterol Jpn       Date:  1984-02

4.  Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer.

Authors:  Ali A Ghweil; Heba A Osman; Mohammed H Hassan; Abeer Mm Sabry; Reem E Mahdy; Ahmed Rh Ahmed; Ahmed Okasha; Ashraf Khodeary; Hesham H Ameen
Journal:  Cancer Manag Res       Date:  2020-01-08       Impact factor: 3.989

5.  Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

Authors:  Hye Won Chung; Sang-Guk Lee; Heejung Kim; Duck Jin Hong; Jae Bock Chung; David Stroncek; Jong-Baeck Lim
Journal:  J Transl Med       Date:  2009-05-28       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.